Rahul A. Parikh, MD, PhD, is leader of genitourinary oncology, and he oversees all clinical and translational research in genitourinary malignancies at The University of Kansas Cancer Center. He is an associate professor of medicine at the University of Kansas Medical Center in Kansas City, Kansas. He enhances the cancer center’s activity in the NRG Oncology and Southwest Oncology Group (SWOG). He has co-authored and published multiple articles, posters and abstracts at national and international meetings.

He received his medical degree from King Edward Memorial Hospital in Mumbai, India. He subsequently pursued a PhD in human genetics in DNA-repair cancer at the University of Pittsburgh. He completed his internal medicine residency and fellowship in hematology/oncology at the University of Pittsburgh Medical Center (UPMC).

Dr. Parikh continued for 6 years as physician-researcher at the University of Pittsburgh, providing care and access to clinical trials for patients with genitourinary cancers. He moved to Kansas in 2017 to be genitourinary cancer program director at the University of Kansas Medical Center. He has a strong interest in medical education and received several awards, including the Alan Winkelstein Award for Fellowship Educator and the David Roodman Excellence in Mentoring Award. He is a successful clinical investigator with a background in bench research focused on DNA-repair pathways in cancer and chemotherapy resistance. He has participated in multiple investigator-initiated, cooperative-group and industry-sponsored clinical studies in genitourinary malignancies. He has enrolled several patients in National Clinical Trials Network (NCTN) trials through his career and, in recognition of his contributions to the NCI Clinical Trials Programs, he was awarded the 2017 Cancer Clinical Investigator Team Leadership Award (CCITLA) by the NIH-NCI.